South San Francisco, CA, United States of America

Edward Yost

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Genentech, Inc.. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward Yost. Retrieved from https://idiyas.com/inventor/edward-yost-4nyrlr5u

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Edward Yost: Innovator in Pharmaceutical Compositions

Introduction

Edward Yost is a notable inventor based in South San Francisco, California, recognized for his contributions to the field of pharmaceuticals. With two patents under his name, Yost has significantly advanced the development of cancer treatments through his innovative work.

Latest Patents

Yost's latest patents focus on pharmaceutical compositions comprising Akt protein kinase inhibitors. These inventions relate to therapeutic compositions that demonstrate effectiveness against diseases such as cancer. The patents outline both the processes for preparing these compounds and their usage as medicaments, highlighting Yost’s commitment to addressing critical health challenges.

Career Highlights

Throughout his career, Edward Yost has worked at Genentech, Inc., a leading biotechnology company known for its innovative research and drug development. His role there has positioned him at the forefront of pharmaceutical innovation, allowing him to make meaningful contributions to medicine and patient care.

Collaborations

Yost has collaborated with notable colleagues, including Pirmin Hidber and Andre Hell. Together, they have worked to enhance the understanding and application of Akt protein kinase inhibitors, further solidifying their impact in the pharmaceutical industry.

Conclusion

Edward Yost’s inventive spirit and dedication have led to significant advancements in pharmaceutical compositions, particularly in the fight against cancer. His work at Genentech, Inc. and collaborations with fellow innovators underscore the importance of teamwork and shared vision in driving scientific progress. As Yost continues to develop groundbreaking treatments, his contributions remind us of the vital role inventors play in healthcare innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…